Login
$INDP
$3.34 +$0.01 (0.3%) Close

Insider Transactions

What Indaptus Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 5

Shares traded

3 months 12 months
Acquired 0 19,125,000
Disposed 0 0
Net activity +0 +19,125,000

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Ben-Tzvi Avraham Director Jan 20 Grant / award · A +25,000 — — 25,100
Meckler Jeffrey A Co-Chief Executive Officer Dec 22 Grant / award · A +216,617 $2.03 +$440K 229,929
Sassi Nir Chief Financial Officer Dec 22 Grant / award · A +26,758 $2.03 +$54.3K 26,758
Linscott Walt Addison Chief Operating Officer Dec 22 Grant / award · A +54,421 $2.03 +$110K 54,426
Newman Michael James CSO and Director Dec 22 Grant / award · A +52,204 $2.03 +$106K 101,074
Meckler Jeffrey A Chief Executive Officer Jul 27 Grant / award · A +6,068 $8.30 +$50.4K 13,312
Meckler Jeffrey A CEO and Director Nov 25 Grant / award · A +42,553 $1.18 +$50K 202,859
Meckler Jeffrey A CEO and Director Aug 08 Grant / award · A +84,932 $1.83 +$155K 160,306
Anderson Glen R. 10% owner Aug 14 Open-market buy · P +23,934 $2.34 +$56K 1,190,400
Anderson Glen R. 10% owner Aug 11 Open-market buy · P +35,064 $2.12 +$74.3K 1,166,466
Anderson Glen R. 10% owner Aug 10 Open-market buy · P +44,354 $1.94 +$86K 1,131,402
Litchev Boyan Vesselinov Chief Medical Officer Dec 01 Open-market buy · P +500 $1.87 +$935 1,150
Litchev Boyan Vesselinov Chief Medical Officer Nov 22 Open-market buy · P +500 $1.83 +$915 650
Meckler Jeffrey A CEO and Director Nov 21 Open-market buy · P +9,600 $1.90 +$18.2K 75,374
Meckler Jeffrey A CEO and Director Nov 18 Open-market buy · P +400 $1.76 +$705 65,774
Meckler Jeffrey A CEO and Director Sep 08 Open-market buy · P +10,308 $2.80 +$28.9K 65,374
Meckler Jeffrey A CEO and Director Sep 07 Open-market buy · P +8,632 $2.57 +$22.2K 55,066
Linscott Walt Addison Chief Business Officer Sep 07 Open-market buy · P +150 $2.62 +$393 150
Meckler Jeffrey A CEO and Director Sep 06 Open-market buy · P +1,060 $2.44 +$2.59K 46,434
Meckler Jeffrey A CEO and Director Jun 06 Open-market buy · P +19,727 $2.63 +$51.9K 45,374

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support